↓ Skip to main content

Apixaban for Extended Treatment of Venous Thromboembolism

Overview of attention for article published in New England Journal of Medicine, December 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Citations

dimensions_citation
1106 Dimensions

Readers on

mendeley
675 Mendeley
citeulike
5 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Apixaban for Extended Treatment of Venous Thromboembolism
Published in
New England Journal of Medicine, December 2012
DOI 10.1056/nejmoa1207541
Pubmed ID
Authors

Giancarlo Agnelli, Harry R Buller, Alexander Cohen, Madelyn Curto, Alexander S Gallus, Margot Johnson, Anthony Porcari, Gary E Raskob, Jeffrey I Weitz

X Demographics

X Demographics

The data shown below were collected from the profiles of 95 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 675 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 5 <1%
Spain 4 <1%
France 4 <1%
Netherlands 4 <1%
Japan 4 <1%
United States 3 <1%
United Kingdom 3 <1%
Denmark 2 <1%
Egypt 2 <1%
Other 8 1%
Unknown 636 94%

Demographic breakdown

Readers by professional status Count As %
Other 122 18%
Researcher 107 16%
Student > Master 73 11%
Student > Postgraduate 71 11%
Student > Bachelor 62 9%
Other 184 27%
Unknown 56 8%
Readers by discipline Count As %
Medicine and Dentistry 438 65%
Pharmacology, Toxicology and Pharmaceutical Science 47 7%
Agricultural and Biological Sciences 37 5%
Nursing and Health Professions 16 2%
Biochemistry, Genetics and Molecular Biology 10 1%
Other 31 5%
Unknown 96 14%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 182. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 September 2023.
All research outputs
#224,444
of 26,017,215 outputs
Outputs from New England Journal of Medicine
#4,144
of 32,765 outputs
Outputs of similar age
#1,340
of 292,215 outputs
Outputs of similar age from New England Journal of Medicine
#35
of 368 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 32,765 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 122.4. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 292,215 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 368 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.